N-[1-[3-[2-[4-(2-methylpropylamino)phenoxy]-1,3-thiazol-5-yl]-1H-pyrazol-5-yl]ethyl]acetamide
C20H25N5O2S — CID 141350287
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[3-[2-[4-(2-methylpropylamino)phenoxy]-1,3-thiazol-5-yl]-1H-pyrazol-5-yl]ethyl]acetamide
N-[1-[3-[2-[4-(2-methylpropylamino)phenoxy]-1,3-thiazol-5-yl]-1H-pyrazol-5-yl]ethyl]acetamide (PubChem CID 141350287) has the molecular formula C20H25N5O2S and a molecular weight of 399.52 g/mol. Its IUPAC name is N-[1-[3-[2-[4-(2-methylpropylamino)phenoxy]-1,3-thiazol-5-yl]-1H-pyrazol-5-yl]ethyl]acetamide.
Molecular Properties
| Compound Name | N-[1-[3-[2-[4-(2-methylpropylamino)phenoxy]-1,3-thiazol-5-yl]-1H-pyrazol-5-yl]ethyl]acetamide |
|---|---|
| PubChem CID | 141350287 |
| Molecular Formula | C20H25N5O2S |
| Molecular Weight | 399.52 g/mol |
| Exact Mass | 399.17 |
| IUPAC Name | N-[1-[3-[2-[4-(2-methylpropylamino)phenoxy]-1,3-thiazol-5-yl]-1H-pyrazol-5-yl]ethyl]acetamide |
| SMILES | CC(=O)NC(C)c1cc(-c2cnc(Oc3ccc(NCC(C)C)cc3)s2)n[nH]1 |
| InChI | InChI=1S/C20H25N5O2S/c1-12(2)10-21-15-5-7-16(8-6-15)27-20-22-11-19(28-20)18-9-17(24-25-18)13(3)23-14(4)26/h5-9,11-13,21H,10H2,1-4H3,(H,23,26)(H,24,25) |
| InChIKey | OLIPETUUKGUNDM-UHFFFAOYSA-N |
| XLogP | 4.59 |
| TPSA | 91.93 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 399.52 |
| LogP ≤ 5 | 4.59 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141350287 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.